Immediate Impact
6 standout
Citing Papers
Antibody–Drug Conjugates (ADCs): current and future biopharmaceuticals
2025 Standout
A review of the clinical efficacy of FDA-approved antibody‒drug conjugates in human cancers
2024 Standout
Works of Damir Gugić being referenced
Prognostic role of Nectin-4 expression in luminal B (HER2 negative) breast cancer
2017
Author Peers
| Author | Last Decade | Papers | Cites | |||||
|---|---|---|---|---|---|---|---|---|
| Damir Gugić | 5 | 18 | 1 | 16 | 11 | 13 | 46 | |
| Xiaofei Jiao | 5 | 28 | 16 | 7 | 12 | 67 | ||
| Miriam Mengoni | 2 | 23 | 17 | 6 | 15 | 67 | ||
| Seyedeh Panid Madani | 6 | 14 | 6 | 6 | 14 | 47 | ||
| Haitao Li | 6 | 27 | 2 | 26 | 7 | 14 | 73 | |
| Mingxin Bai | 3 | 12 | 2 | 21 | 13 | 16 | 79 | |
| Tasleema Patel | 8 | 12 | 2 | 9 | 23 | 9 | 69 | |
| Vlad Alexandru Gâta | 8 | 27 | 28 | 18 | 15 | 72 | ||
| G Wagner | 21 | 13 | 19 | 16 | 8 | 56 | ||
| Monika A. Zelazowska | 9 | 22 | 1 | 10 | 16 | 10 | 51 | |
| O Mioduszewska | 9 | 20 | 1 | 17 | 4 | 13 | 66 |
All Works
Loading papers...